APSR2026-738

Yes
Late-Breaking
Submitted
Poster Presentation
 
AP11-015
P57
 
Format: PPTX Only
https://storage.unitedwebnetwork.com/files/1285/1221167-46904-APSR26_Poster Oman Final_434810.pdf
Format: PDF Only
09. Asthma
5

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

Laila Najeeb * Badr Al Samaa Hospital, Al khoudh, Oman Consultant Pulmonologist Oman Oman
Pushplata Kadam - Cipla Ltd Global Medical Affairs Mumbai India
Anniruddha Mukhopadhyay - Cipla Ltd Global Medical Affairs Mumbai India
Jaideep Gogtay - Cipla Ltd Global Medical Affairs Mumbai India
Vaibhav Gaur - Cipla Ltd Global Medical Affairs Mumbai India
 
 
 
 
 
 
 
 
 
 
Presenting Author Details
Laila
Najeeb
pushplata.kadam@cipla.com
+919969415681
31-40
Oman
Original Research
Perception on the Management of Asthma: A perception Survey of Clinicians in Oman
Maximum 25 words
Abstract Content
This survey aimed to evaluate asthma management practices in Oman by examining clinicians’ experiences, prescribing behaviors, and treatment preferences across varying asthma severities.
A cross-sectional, questionnaire-based survey was conducted among 38 clinicians from Muscat and Sohar comprising physicians and general practitioners.
Clinicians reported a broad spectrum of asthma severities among their patients 61% were categorized as Global Initiative for Asthma [GINA] Steps 1–2, 23% as Step 3, 10% as Step 4, and 5% as Step 5. Most patients were aged ≥12 years, and approximately 13% used alternative therapies such as Ayurveda or Hijama. The primary contributors to poor asthma control were irregular medication use (61%), incorrect inhaler technique (42%), and exposure to environmental triggers, particularly dust (47%). Treatment choices were predominantly driven by clinical experience (87%) and established guideline recommendations (79%). For GINA Step 1–2, clinicians mainly preferred as-needed low-dose ICS/formoterol as the reliever (54%), while as-needed low-dose ICS (22%) and as-needed ICS/formoterol (49%) were commonly selected controller options. In GINA Steps 3–5, 67% prescribed ICS/formoterol, with a notable preference for pressurized metered-dose inhalers (pMDIs) (68%) over dry powder inhalers (DPIs) (35%). Clinicians estimated that 74% of patients were capable of effectively using maintenance and reliever therapy (MART). Clinicians reported that 32% of patients were reluctant to start inhalation therapy, largely due to misconceptions about dependence, concerns regarding side effects, and limited awareness. Despite using inhalers, approximately 16% of patients still require emergency care or hospitalization. Regular follow‑up visits (47%) and patient education materials (42%) were the most employed strategies to improve adherence and address treatment hesitancy.
Clinicians demonstrated a consistent preference for ICS/formoterol across asthma severities and expressed strong confidence in MART. The findings underscore the need to enhance inhaler technique training, optimize device selection, and strengthen adherence-focused interventions.
 
 
 
 
 
No
No
 
JPG or JPEG or PNG format ONLY
Maintenance and reliever therapy (MART), Asthma management, GINA guidelines
maximum 3 keywords and no abbreviations, separated by commas
 
298